Get to know more about GI issues and our solution.
Bold Health has been selected to be part of KQ Labs, an accelerator program at Francis Crick Institute in London
Earlier this month, the company launched its first product, Zemedy, an app targeted at treating irritable bowel syndrome.
Bold Health is proud to be presenting at Biotech Showcase™ 2020 in San Francisco.
The InnovateUK grant will partly fund continuing research between Bold Health and the University College London Hospitals NHS
The 21st Century Icon awards is the ultimate platform to connect the next generation of inspiring leaders and businesses.
We're very proud to be a female-led company and to be featured on the latter category: Digital Wellbeing.
A randomized controlled trial is set to prove the benefits of the Zemedy mobile app in patients with Irritable Bowel Syndrome.